Nevirapine or efavirenz for tuberculosis and HIV coinfected patients: exposure and virological failure relationship
| dc.contributor.author | Bhatt, N B | |
| dc.contributor.author | Baudin, E | |
| dc.contributor.author | Meggi, B | |
| dc.contributor.author | da Silva, C | |
| dc.contributor.author | Barrail-Tran, A | |
| dc.contributor.author | Furlan, V | |
| dc.contributor.author | Grinsztejn, B | |
| dc.contributor.author | Bonnet, M | |
| dc.contributor.author | Taburet, A-M | |
| dc.date.accessioned | 2014-12-11T22:40:13Z | |
| dc.date.available | 2014-12-11T22:40:13Z | |
| dc.date.issued | 2014-09-18 | |
| dc.identifier.citation | Nevirapine or efavirenz for tuberculosis and HIV coinfected patients: exposure and virological failure relationship. 2014: J. Antimicrob. Chemother. | en_GB |
| dc.identifier.issn | 1460-2091 | |
| dc.identifier.pmid | 25239466 | |
| dc.identifier.doi | 10.1093/jac/dku348 | |
| dc.identifier.uri | http://hdl.handle.net/10144/337110 | |
| dc.description.abstract | We describe nevirapine and efavirenz exposure on and off tuberculosis treatment and consequences for virological efficacy and tolerance in patients included in the ANRS 12146/12214-CARINEMO trial. | |
| dc.language | ENG | |
| dc.language.iso | en | en |
| dc.publisher | Oxford University Press | en_GB |
| dc.rights | Archived with thanks to The Journal of Antimicrobial Chemotherapy and Oxford University Press | en_GB |
| dc.title | Nevirapine or efavirenz for tuberculosis and HIV coinfected patients: exposure and virological failure relationship | en |
| dc.identifier.journal | Journal of Antimicrobial Chemotherapy | en_GB |
| refterms.dateFOA | 2019-03-04T11:39:33Z | |
| html.description.abstract | We describe nevirapine and efavirenz exposure on and off tuberculosis treatment and consequences for virological efficacy and tolerance in patients included in the ANRS 12146/12214-CARINEMO trial. |
Files in this item
Name:
Bhatt N et al - 2014 - Nevirapine ...
Size:
250.7Kb
Format:
PDF
Description:
Main article